Role of Apobecs in Retroviral Immunity
Apobecs 在逆转录病毒免疫中的作用
基本信息
- 批准号:9756136
- 负责人:
- 金额:$ 45.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-25 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectB-LymphocytesBetaretrovirusBiological AssayBiotinylationC-terminalCapsidCell Culture TechniquesCellsChimeric ProteinsCleaved cellCommunicable DiseasesComplexConsensus SequenceCullin ProteinsCytosineCytosine deaminaseDNADataDeaminaseDeaminationDendritic CellsDevelopmentEndoplasmic ReticulumEndoplasmic Reticulum Degradation PathwayEnzymesFamilyFamily memberGenesGeneticGrowthHIVHIV-1Hepatitis BHerpesviridaeHumanImmune responseImmunityImmunoglobulin Class SwitchingImmunoglobulin Somatic HypermutationImmunoglobulin Switch RecombinationImmunoglobulin Variable RegionIn VitroInbred BALB C MiceIncidenceInduced MutationInfectionInfectious AgentInnate Immune ResponseKnock-outKnockout MiceLaboratoriesLinkMalignant NeoplasmsMammary NeoplasmsMammary glandMass Spectrum AnalysisMediatingMembraneMessenger RNAMilkMouse Mammary Tumor VirusMusMutationN-terminalNatural ImmunityNewborn InfantOrganizational ModelsPapillomavirusPeptide Signal SequencesProteasome InhibitorProtein PrecursorsProteinsProvirusesRNARNA SplicingRetrotranspositionRetrotransposonRetroviridaeReverse TranscriptionRoleSpecificitySubfamily lentivirinaeT-LymphocyteTechnologyTestingTransfectionTranslatingUbiquitinUbiquitinationUracilVariantViralVirionVirusVirus ReplicationWild Type Mouseactivation-induced cytidine deaminaseadaptive immune responseadaptive immunityapolipoprotein B mRNA editing enzymebasecell typeenv Gene Productsexperimental studygenetic regulatory proteinhuman diseaseimprovedin vivoin vivo evaluationinhibitor/antagonistmalignant breast neoplasmmembermulticatalytic endopeptidase complexmutantpathogenpolypeptidesignal peptidasetissue culturetransition mutationtumorubiquitin-protein ligaseviral transmission
项目摘要
Project Summary
Innate immunity requires cellular restriction factors that inhibit the replication of multiple pathogens.
One group of restriction factors is the apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like
(Apobec) family of cytosine deaminases, including activation-induced cytosine deaminase (AID). AID
function includes both innate and adaptive immune responses due to its role in control of retrotransposons
as well as somatic hypermutation of immunoglobulin variable regions and class switch recombination.
Apobec family enzymes are known inhibitors of complex human retroviruses, such as the lentivirus human
immunodeficiency virus (HIV-1), as well as DNA-containing viruses. HIV-1 encodes an Apobec antagonist,
Vif and, in the absence of Vif, the provirus sustains high numbers of G to A hypermutations due to cytosine
deamination on the minus strand during reverse transcription. My laboratory has shown that mouse
mammary tumor virus (MMTV) is the only known complex mouse retrovirus with organizational and
functional features similar to HIV, such as the regulatory protein Rem. Rem is a precursor protein that is
cleaved by signal peptidase at the ER membrane to give an N-terminal signal peptide (SP) that has Rev-like
function and a C-terminal protein of unknown function. Inoculation of cloned MMTV lacking Rem
expression into BALB/c mice resulted in mammary tumors with a decreased incidence and latency
compared to wild-type MMTV. Characterization of MMTV proviruses from these mammary tumors showed
extensive G to A as well as other transition mutations on both DNA strands, consistent with AID-type
mutations, but also some typical of the consensus sequences and strand specificity of murine Apobec3
(mA3) or other deaminases. Transfection experiments revealed proteasomal degradation of AID in the
presence of Rem, but not mA3. These results led us to the hypothesis that Rem is an HIV-1 Vif-like
antagonist of multiple Apobec cytosine deaminases. This application will test several aspects of this
hypothesis. In Aim 1, we will determine sequences within Rem and AID that are necessary for proteasomal
degradation. We will identify the E3 ligase for AID protein interactions in the presence and absence of Rem
using screens that detect biotinylation of interacting proteins by BirA or conjugation to an AID-ubiquitin
fusion protein. The role of Rem retrotranslocation for AID degradation will be investigated. In Aim 2,
MMTVs or T-cell variants lacking Rem expression will be used to determine the types of transition mutations
observed in proviruses after infections of knockout mice lacking one or more Apobec genes. These studies
will use a complex mouse retrovirus to explore aspects of innate immunity that are difficult to test in vivo
with human viruses. Our experiments will provide improved understanding of Apobec function as well as
potential application to the treatment of human infectious diseases and cancers.
项目摘要
先天免疫需要细胞限制因子来抑制多种病原体的复制。
一组限制性因子是载脂蛋白B mRNA编辑酶,催化多肽样酶,
(Apobec)胞嘧啶脱氨酶家族,包括活化诱导的胞嘧啶脱氨酶(AID)。援助
由于其在逆转录转座子控制中的作用,其功能包括先天性和适应性免疫应答
以及免疫球蛋白可变区的体细胞超突变和类别转换重组。
Apobec家族酶是复杂的人逆转录病毒(如慢病毒人逆转录病毒)的已知抑制剂。
免疫缺陷病毒(HIV-1)以及含DNA的病毒。HIV-1编码Apobec拮抗剂,
Vif,并且在Vif缺失的情况下,由于胞嘧啶,前病毒维持高数量的G到A超突变。
反转录过程中负链的脱氨作用。我的实验室已经证明老鼠
乳腺肿瘤病毒(MMTV)是唯一已知的复杂的小鼠逆转录病毒,
功能特征类似于HIV,如调节蛋白Rem。Rem是一种前体蛋白,
在ER膜上被信号肽酶切割,得到N-末端信号肽(SP),
功能和未知功能的C-末端蛋白质。接种缺乏Rem的克隆MMTV
在BALB/c小鼠中的表达导致乳腺肿瘤的发生率和潜伏期降低
与野生型MMTV相比。来自这些乳腺肿瘤的MMTV前病毒的特征显示
广泛的G到A以及两条DNA链上的其他转换突变,与艾滋病类型一致
突变,但也有一些典型的共有序列和链特异性的小鼠Apobec 3
(mA3)或其它脱氨酶。转染实验表明,在细胞中AID的蛋白酶体降解。
存在Rem,但不存在mA 3。这些结果使我们假设Rem是一种HIV-1 Vif样蛋白,
多种Apobec胞嘧啶脱氨酶的拮抗剂。这个应用程序将测试几个方面
假说.在目标1中,我们将确定Rem和AID中蛋白酶体必需的序列,
降解我们将鉴定在存在和不存在Rem的情况下AID蛋白相互作用的E3连接酶
使用通过BirA检测相互作用蛋白质的生物素化或与AID-泛素缀合的筛选
融合蛋白将研究Rem逆易位对AID降解的作用。在目标2中,
MMTV或缺乏Rem表达的T细胞变体将用于确定转换突变的类型
在缺乏一个或多个Apobec基因的敲除小鼠感染后的前病毒中观察到。这些研究
将使用一种复杂的小鼠逆转录病毒来探索先天免疫的各个方面,这些方面很难在体内进行测试
人类病毒。我们的实验将提供对Apobec功能的更好理解,
在治疗人类感染性疾病和癌症中的潜在应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jaquelin Page Dudley其他文献
Jaquelin Page Dudley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jaquelin Page Dudley', 18)}}的其他基金
Endogenous Retroviruses and the Immune Response to Pathogens
内源性逆转录病毒和对病原体的免疫反应
- 批准号:
8652435 - 财政年份:2013
- 资助金额:
$ 45.28万 - 项目类别:
Endogenous Retroviruses and the Immune Response to Pathogens
内源性逆转录病毒和对病原体的免疫反应
- 批准号:
8492239 - 财政年份:2013
- 资助金额:
$ 45.28万 - 项目类别:
Retroviral Subversion of ERAD and Intrinsic Immunity
ERAD 和内在免疫的逆转录病毒颠覆
- 批准号:
8542800 - 财政年份:2012
- 资助金额:
$ 45.28万 - 项目类别:
Retroviral Subversion of ERAD and Intrinsic Immunity
ERAD 和内在免疫的逆转录病毒颠覆
- 批准号:
8687620 - 财政年份:2012
- 资助金额:
$ 45.28万 - 项目类别:
Retroviral Subversion of ERAD and Intrinsic Immunity
ERAD 和内在免疫的逆转录病毒颠覆
- 批准号:
8438721 - 财政年份:2012
- 资助金额:
$ 45.28万 - 项目类别:
相似海外基金
Characterizing RNA regulation in B lymphocytes
B 淋巴细胞中 RNA 调控的特征
- 批准号:
502601 - 财政年份:2024
- 资助金额:
$ 45.28万 - 项目类别:
Characterization of Streptococcus suis interactions with B lymphocytes
猪链球菌与 B 淋巴细胞相互作用的表征
- 批准号:
573206-2022 - 财政年份:2022
- 资助金额:
$ 45.28万 - 项目类别:
University Undergraduate Student Research Awards
Altered B lymphocytes Due to Tungstate Exposure
钨酸盐暴露导致 B 淋巴细胞发生改变
- 批准号:
RGPIN-2020-05899 - 财政年份:2022
- 资助金额:
$ 45.28万 - 项目类别:
Discovery Grants Program - Individual
The regulation of signaling and cytoskeletal rearrangements in B-lymphocytes
B 淋巴细胞信号传导和细胞骨架重排的调节
- 批准号:
RGPIN-2019-04911 - 财政年份:2022
- 资助金额:
$ 45.28万 - 项目类别:
Discovery Grants Program - Individual
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
- 批准号:
10543825 - 财政年份:2022
- 资助金额:
$ 45.28万 - 项目类别:
Myocardial-associated B lymphocytes and inflammatory injury
心肌相关B淋巴细胞与炎症损伤
- 批准号:
10339541 - 财政年份:2022
- 资助金额:
$ 45.28万 - 项目类别:
Exploring RNA helicase DDX the role of the1 at the crossroad of DNA repair processes in B lymphocytes
探索 RNA 解旋酶 DDX 在 B 淋巴细胞 DNA 修复过程十字路口的作用
- 批准号:
BB/X511560/1 - 财政年份:2022
- 资助金额:
$ 45.28万 - 项目类别:
Training Grant
Role and regulation of extracellular vesicles generated in response to stimulation of CD24 on B lymphocytes
B 淋巴细胞上 CD24 刺激产生的细胞外囊泡的作用和调节
- 批准号:
RGPIN-2022-03800 - 财政年份:2022
- 资助金额:
$ 45.28万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




